QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=A4A9A86198E2EB02EF7B605E589284D5;jsessionid=4F3393A95B4552BF3BB6E350B20E0541;jsessionid=E99064A2B4B2CEC10789342FCB8ED3F1;jsessionid=A0AD4FE854292D9822AED46766BCE8D1;jsessionid=E72C79A8B7722D64E1262D0CFF3948F1;jsessionid=5204BC50BAC3272803AB32B39E71C08B;jsessionid=850EEB5B8D8D617AD08F44B6E085769A (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=A4A9A86198E2EB02EF7B605E589284D5;jsessionid=4F3393A95B4552BF3BB6E350B20E0541;jsessionid=E99064A2B4B2CEC10789342FCB8ED3F1;jsessionid=A0AD4FE854292D9822AED46766BCE8D1;jsessionid=E72C79A8B7722D64E1262D0CFF3948F1;jsessionid=5204BC50BAC3272803AB32B39E71C08B;jsessionid=850EEB5B8D8D617AD08F44B6E085769A